OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)	209
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset	174
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients	99
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID‐19 patients with pneumonia	93
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno‐oncology treatments	87
Human NK cells, their receptors and function	82
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action	76
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy	70
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans	67
MDSC subtypes and CD39 expression on CD8⁺ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC	58
Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity	56
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway	56
Highly multiplexed tissue imaging using repeated oligonucleotide exchange reaction	53
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15	52
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients	50
JAK inhibitors: Ten years after	50
The expanding world of tissue‐resident macrophages	50
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris	49
TNF‐α and IL‐1β sensitize human MSC for IFN‐γ signaling and enhance neutrophil recruitment	48
CD8⁺ Tregs revisited: A heterogeneous population with different phenotypes and properties	47
Treg cell therapy: How cell heterogeneity can make the difference	47
Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease	43
Complement cascade in severe forms of COVID‐19: Recent advances in therapy	43
CAR T cells: Building on the CD19 paradigm	42
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development	41

Immune response in children with COVID‐19 is characterized by lower levels of T‐cell activation than infected adults	40
Tc17 biology and function: Novel concepts	40
Helios is a marker, not a driver, of human Treg stability	39
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients	38
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8⁺ T cells	38
Comprehensive characterization of myeloid cells during wound healing in healthy and healing‐impaired diabetic mice	35
Metabolic reprograming shapes neutrophil functions in severe COVID‐19	35
Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils	33
The role of the gut microbiota and microbial metabolites in neuroinflammation	32
Altered increase in STAT1 expression and phosphorylation in severe COVID‐19	32
Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis	32
Loss of core fucosylation enhances the anticancer activity of cytotoxic T lymphocytes by increasing PD‐1 degradation	32
Manipulation of epithelial integrity and mucosal immunity by host and microbiota‐derived metabolites	32
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy	32
Regulatory T‐cell development in the tumor microenvironment	31
The thioredoxin‐1 inhibitor Txnip restrains effector T‐cell and germinal center B‐cell expansion	31
Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α	31
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination	31
Anti‐heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID‐19	31
Tumor‐derived microparticles in tumor immunology and immunotherapy	30
IL‐17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone‐forming cells in ankylosing spondylitis	30
A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice	30
LIPS method for the detection of SARS‐CoV‐2 antibodies to spike and nucleocapsid proteins	30
Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity	29
Palmitate‐TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing	29
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver	28
Altered IgG glycosylation at COVID‐19 diagnosis predicts disease severity	28
Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection	28
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis	27
Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer	27
Molecular mechanisms of nonself nucleic acid recognition by the innate immune system	27
Antigen‐driven PD‐1⁺TOX⁺BHLHE40⁺ and PD‐1⁺TOX⁺EOMES⁺ T lymphocytes regulate juvenile idiopathic arthritis	26
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver	26
Dysregulation in B‐cell responses and T follicular helper cell function in ADA2 deficiency patients	26
Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs	25
Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease	25
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects	24
Neuroimmune interactions in peripheral tissues	24
COVID‐19 vaccines: Knowing the unknown	24
Fibroblast‐derived IL‐33 is dispensable for lymph node homeostasis but critical for CD8 T‐cell responses to acute and chronic viral infection	24
Protection against allergies: Microbes, immunity, and the farming effect	24
‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity	23
Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer	23
RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches	23
Enrichment of CCR6⁺CD8⁺ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID‐19	23
The association of Epstein‐Barr virus infection with CXCR3⁺ B‐cell development in multiple sclerosis: impact of immunotherapies	23
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis	23
Collagen type VI is the antigen recognized by the ER‐TR7 antibody	23
Maintenance of quiescent immune memory in the bone marrow	22
IL‐33/ST2 as a potential target for tumor immunotherapy	22

Upregulation of CCR4 in activated CD8⁺ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection	22
Identification of human cytotoxic ILC3s	22
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients	22
Circulating memory CD8⁺ T cells are limited in forming CD103⁺ tissue‐resident memory T cells at mucosal sites after reinfection	22
An integrative genomics approach identifies KDM4 as a modulator of trained immunity	22
Mechanisms of exTreg induction	22
Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo	22
The role of cGAS/STING in intestinal immunity	22
Sestrin1 inhibits oxidized low‐density lipoprotein‐induced activation of NLRP3 inflammasome in macrophages in a murine atherosclerosis model	22
Regulation of the humoral type 2 immune response against allergens and helminths	22
Measuring single‐cell protein secretion in immunology: Technologies, advances, and applications	22
CTRP4 acts as an anti‐inflammatory factor in macrophages and protects against endotoxic shock	21
Innate lymphoid cells and cancer: Role in tumor progression and inhibition	21
Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects	21
Autophagy regulates long‐term cross‐presentation by murine dendritic cells	20
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy	20
Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay	20
Deep phenotypical characterization of human CD3⁺CD56⁺ T cells by mass cytometry	20
Malaria exposure drives both cognate and bystander human B cells to adopt an atypical phenotype	19
T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation	19
High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2	19
TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis	18
PD‐1‐specific “Blocking” antibodies that deplete PD‐1⁺ T cells present an inconvenient variable in preclinical immunotherapy experiments	18
Human dendritic cell subsets: An updated view of their ontogeny and functional specialization	18
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	18
CD5 levels define functionally heterogeneous populations of naïve human CD4⁺ T cells	18
Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice	18
ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitro	17
White matter lesions in multiple sclerosis are enriched for CD20^dim CD8⁺ tissue‐resident memory T cells	17
Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis	17
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses	17
HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis	17
De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cells	17
Tryptophan and the innate intestinal immunity: Crosstalk between metabolites, host innate immune cells, and microbiota	17
Fetal‐derived macrophages persist and sequentially maturate in ovaries after birth in mice	17
Cross talk between human regulatory T cells and antigen‐presenting cells: Lessons for clinical applications	17
Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance	16
Specificity of mouse and human Fcgamma receptors and their polymorphic variants for IgG subclasses of different species	16
Withdrawn	16
Towards prevention of autoimmune diseases: The example of rheumatoid arthritis	16
Metabolic dynamics instruct CD8⁺ T‐cell differentiation and functions	16
Geranylgeranyl pyrophosphate amplifies T_reg differentiation via increased IL‐2 expression to ameliorate DSS‐induced colitis	16
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein	16
Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis	16
Towards gene therapy for IPEX syndrome	16
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model	16
Interleukin‐17 producing mucosal associated invariant T cells ‐ emerging players in chronic inflammatory diseases?	16
SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10	16
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches	16
Innate immune evasion by picornaviruses	16
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes‐1 negatively regulates human neutrophils	15
Human pregnancy levels of estrogen and progesterone contribute to humoral immunity by activating T_FH/B cell axis	15
Transcriptional meta‐analysis of regulatory B cells	15
Insights into coronavirus immunity taught by the murine coronavirus	15
The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19	15
4‐1BB costimulation promotes bystander activation of human CD8 T cells	15
AIDS patient with severe T cell depletion achieved control but not clearance of SARS‐CoV‐2 infection	15
T‐cell memory in tissues	15
Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children	15
Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer	15
Heterogeneity of germinal center B cells: New insights from single‐cell studies	15
Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive	15
Human liver‐derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR‐independent activation	14
A novel method to identify Post‐Aire stages of medullary thymic epithelial cell differentiation	14
Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes	14
Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions	14
Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis	14
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection	14
GSDMD‐mediated NETosis promotes the development of acute respiratory distress syndrome	14
Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis	14
Pharmacological inhibition of RORC2 enhances human Th17‐Treg stability and function	14
miR‐148a controls metabolic programming and survival of mature CD19‐negative plasma cells in mice	13
Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience	13
Molecular characterization of HLA class II binding to the LAG‐3 T cell co‐inhibitory receptor	13
Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities	13
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer	13
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies	13
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming	13
Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice	13
Abortive HIV‐1 RNA induces pro‐IL‐1β maturation via protein kinase PKR and inflammasome activation in humans	12

CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts	12
IgE in the pathophysiology and therapy of food allergy	12
Broadly reactive human CD4⁺ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire	12
The thioredoxin system: Balancing redox responses in immune cells and tumors	12
ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination	12
Tissue‐resident mucosal‐associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset	12
Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity	12
Human myeloid‐derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data	12
Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis	12
Loss of microRNA‐147 function alleviates synovial inflammation through ZNF148 in rheumatoid and experimental arthritis	12
Sphingosine 1‐phosphate/microRNA‐1249‐5p/MCP‐1 axis is involved in macrophage‐associated inflammation in fatty liver injury in mice	12
Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response of tissue‐resident memory T cells against the AH1 rejection antigen	12
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders	11
Advanced glycation end products reduce macrophage‐mediated killing of Staphylococcus aureus by ARL8 upregulation and inhibition of autolysosome formation	11
Differential effects of estradiol and progesterone on human T cell activation in vitro	11
Conventional type 1 dendritic cells induce T_H1, T_H1‐like follicular helper T cells and regulatory T cells after antigen boost via DEC205 receptor	11
Transcriptomic profiling of bovine blood dendritic cells and monocytes following TLR stimulation	11
Four challenges to CAR T cells breaking the glass ceiling	11
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells	11
Evidence for an involvement of the ubiquitin‐like modifier ISG15 in MHC class I antigen presentation	11
Trigger‐dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis	11
Human NK cells responses are enhanced by CD56 engagement	11
Human CXCR5⁺PD‐1⁺ CD8 T cells in healthy individuals and patients with hematologic malignancies	11
Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline	11
Cell surface IL‐1α trafficking is specifically inhibited by interferon‐γ, and associates with the membrane via IL‐1R2 and GPI anchors	11
TFF3 mediates the NF‐κB/COX2 pathway to regulate PMN‐MDSCs activation and protect against necrotizing enterocolitis	11
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods	11
One year of Young EFIS: achievements and future directions	11
Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results	10
Interleukin‐21 in autoimmune and inflammatory skin diseases	10
CD73 contributes to anti‐inflammatory properties of afferent lymphatic endothelial cells in humans and mice	10
TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction	10
Guidelines for mouse and human DC generation	10
Cross‐presentation of dead‐cell‐associated antigens by DNGR‐1⁺ dendritic cells contributes to chronic allograft rejection in mice	10
Regulatory T cells as a therapeutic approach for inflammatory bowel disease	10
IL‐31 transgenic mice show reduced allergen‐induced lung inflammation	10
Peritoneal dialysate‐range hypertonic glucose promotes T‐cell IL‐17 production that induces mesothelial inflammation	10
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies	10
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients	10
Macrophage plasticity as a therapeutic target in tuberculosis	10
Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells	10
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency	10
Young EFIS ‐ joining forces to support Early Career Researchers in Immunology	10
Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes	10
MS4A4A Regulates Arginase 1 Induction during Macrophage Polarization and Lung Inflammation in Mice	10
Splenic erythroid progenitors decrease TNF‐α production by macrophages and reduce systemic inflammation in a mouse model of T cell‐induced colitis	10
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice	10
Blood microparticles are a component of immune modulation in red blood cell transfusion	10
COVID‐19 rapidly increases MDSCs and prolongs innate immune dysfunctions	10
Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single‐cell analysis	10
Altered follicular regulatory T (Tfr)‐ and helper T (Tfh)‐cell subsets are associated with autoantibody levels in microscopic polyangiitis patients	9
Genetic dissection of a major haplotype associated with arthritis reveal FcγR2b and FcγR3 to act additively	9
Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity	9
Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases	9
Hobit and Blimp‐1 regulate T_RM abundance after LCMV infection by suppressing tissue exit pathways of T_RMprecursors	9
Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay	9
TNFR2 expression is a hallmark of human memory B cells with suppressive function	9
Th17 lymphocyte‐dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab	9
Stereotyped B‐cell responses are linked to IgG constant region polymorphisms in multiple sclerosis	9
SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination	9
Epigenetic regulation in antiviral innate immunity	9
Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility	9
Plasmacytoid dendritic cells regulate host immune response to Citrobacter rodentium induced colitis in colon‐draining lymph nodes	9
Migration of murine intestinal dendritic cell subsets upon intrinsic and extrinsic TLR3 stimulation	9
Endoplasmic reticulum stress and the inflammatory response in allergic contact dermatitis	8
Robust intrathymic development of regulatory T cells in young NOD mice is rapidly restrained by recirculating cells	8
Single‐cell resolution of plasma cell fate programming in health and disease	8
Induction of diverse T cell memory through antibody‐mediated activation in mice	8
IL‐10 promotes malignant pleural effusion by regulating T_H1 response via an miR‐7116‐5p/GPR55/ERK pathway in mice	8
Human T cells interacting with HNSCC‐derived mesenchymal stromal cells acquire tissue‐resident memory like properties	8
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function	8
P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell death	8
UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation	8
Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis	8
Multiomics uncovers developing immunological lineages in human	8
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity	8
Nurse shark T‐cell receptors employ somatic hypermutation preferentially to alter alpha/delta variable segments associated with alpha constant region	8
CD8⁺ T cells are crucial for humoral immunity establishment by SA14‐14‐2 live attenuated Japanese encephalitis vaccine in mice	8
CRISPR/Cas9 editing in conditionally immortalized HoxB8 cells for studying gene regulation in mouse dendritic cells	8
Nitrosonisoldipine is a selective inhibitor of inflammatory caspases and protects against pyroptosis and related septic shock	8
Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis	8
Old age‐associated enrichment of peripheral T regulatory cells and altered redox status in pulmonary tuberculosis patients	8
T helper cell subsets: diversification of the field	8
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity	8
Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells	8
Commensal fungi and their cell‐wall β‐glucans direct differential responses in human intestinal epithelial cells	8
CD28 is expressed by macrophages with anti‐inflammatory potential and limits their T‐cell activating capacity	8
Antigen targeting to dendritic cells: Still a place in future immunotherapy?	8
Identification of the Fc‐alpha/mu receptor in Xenopus provides insight into the emergence of the poly‐Ig receptor (pIgR) and mucosal Ig transport	8
Interleukin‐34 accelerates intrauterine adhesions progress related to CX3CR1⁺ monocytes/macrophages	8
Bystander activation of Bordetella pertussis‐induced nasal tissue‐resident memory CD4 T cells confers heterologous immunity to Klebsiella pneumoniae	8
Emerging imaging and liquid biomarkers in multiple sclerosis	8
A conserved pathway of transdifferentiation in murine Kupffer cells	8
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity	8
CD11c identifies microbiota and EGR2‐dependent MHCII⁺ serous cavity macrophages with sexually dimorphic fate in mice	8